Bank of Japan Signals Potential Rate Hike as Inflation Risks Rise Amid Energy Shock 
US and EU Strengthen Critical Minerals Partnership to Reduce China Dependence 
Iran-Pakistan Diplomacy and Strait of Hormuz Tensions Push Oil Prices Above $100 
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window 
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift 
New Zealand Economy Faces Short-Term Pressure but Recovery Remains on Track 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia 
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure 
Dollar Gains as Middle East Tensions and Rising Oil Prices Support Safe-Haven Demand 
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges 
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions 
Japan Inflation Rises in March Amid Energy Price Surge and Middle East Tensions 
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 
Gold Prices Edge Higher Amid Middle East Tensions and Ceasefire Uncertainty 
Wall Street Hits Record High as Tech Stocks Surge Amid U.S.-Iran Developments 
India-US Trade Talks Advance Toward $500 Billion Goal Amid Ongoing Negotiations 
GSK Consumer Healthcare Korea was revealed to have appointed a new chief executive officer, and it was revealed to be Shin Dong Woo, a former CEO of the company’s branch in Hong Kong.
According to The Korea Times, GSK Consumer Healthcare Korea announced the assignment of CEO Shin earlier this week. It was reported that the new chief has been with the company for 28 years and has led GSK in various international businesses - from consumer health care to general consumer goods.
He also led other health care firms such as Pfizer and Sanofi. Prior to his assignment as the new chief at GSK Consumer Healthcare Korea, he has been leading the Honk Kong unit for the last two years. During his tenure, he has many achievements, including boosting the business and building the foundation for its stability.
At Sanofi Korea, he became the first president of the He also completed the company's integration with Pfizer Consumer Healthcare, where he was CEO of the Korean branch and the Asia-Pacific region between 2015 and 2020.
Shin also became the very first president of the French multinational healthcare company’s Korean unit. He helped established the brand in the country and introduced major products that are now selling very well here., and this is not all. Shin has extensive experience in marketing as well as he worked at Coca-Cola, L’Oreal, and Fox Home Entertainment and was in charge of marketing and sales for more than a decade.
Meanwhile, Shin will lead GSK Consumer Healthcare Korea, which has recently changed its name to Haleon. This will be the company’s official name as it starts its consumer healthcare venture. The name means the company will also change all of its product packaging.
"With the announcement of 'Haleon' today, we are one step closer to our goal of becoming a consumer healthcare company,” Haleon’s CEO-nominee, Brian McNamara, said in a press release in February. “'Haleon' will stand as a leader in the consumer healthcare industry with the vision of delivering better daily health to mankind.”
“Haleon” is the outcome of the successful merging of Novartis in 2015 and Pfizer's consumer healthcare portfolio in 2019 over the past eight years.
